Red Arrow Therapeutics, Inc. (“Red Arrow”) is an innovative Japanese biotech company that aims to transform the traditional therapeutic into a next-generation therapy for cancer diseases by maximizing the drug potency with minimum toxicity.
Total raised: $4.5M
Investors 2
Date | Name | Website |
05.04.2023 | Berkeley S... | skydeck.be... |
22.01.2023 | The Univer... | ut-ec.co.j... |
Funding Rounds 1
Date | Series | Amount | Investors |
23.04.2024 | Seed | $4.5M | - |
Mentions in press and media 4
Date | Title | Description | Source |
23.04.2024 | Osaka University Venture Capital Co., Ltd. Made an investmen... | Osaka University Venture Capital Co., Ltd. Made an investment in “Red Arrow Therapeutics, Inc.” …… [... | re-how.net... |
23.04.2024 | Red Arrow Therapeutics Closes $4.5M Seed Extension Funding | Red Arrow Therapeutics Inc., a Boston, MA-based developer of pH-sensing nanomedicine drug delivery t... | finsmes.co... |
23.04.2024 | Keio Innovation Initiative (KII) KII invests in Red Arrow Th... | Keio Innovation Initiative (KII) KII invests in Red Arrow Therapeutics, which develops next-generati... | re-how.net... |
- | Red Arrow Therapeutics | “HOME | Red Arrow Theraputic” | fastfounde... |